At month 12 there were numerical improvements in all W-BQ12 subscale scores, but these did not reach statistical significance.
← all excerpts
Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study.
1
—
—